NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Emerging Disease


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
New desalination study results from University of Strathclyde described
2009 NOV 28 ... AE Amsterdam, Netherlands.Keywords: Country:Scotland, Conservation, Ecology, Emerging Technologies, Environment, Logistic Regression, Machine Learning, Pediatrics, ... out health interventions aimed at achieving measurable results in major causes of disease and death in four villages in Chikwawa, a southern district in Malawi. A baseline survey ...
Subject: Desalination
Price: $3.00
*
New life sciences study findings reported from University of Federico II
2009 NOV 24 ... chromosome aberration (CA) test to better characterize chromosome instability already emerging in a preliminary study where we found a significantly higher difference (p <0.001) in ... in Mutagenesis. According to a study from Naples, Italy, "For several years, a genetic disease called transversal hemimelia (TH), also known as congenital amputation, has been ...
Subject: Life Sciences
View Free
Daily News
Article
PIKAMAB to Customize Cancer Antibody Therapies
2009 NOV 23 ... critical roles including the killing and phagocytosis of cancer cells. About PIKAMAB: An emerging industry leader in stratified medicine, PIKAMAB (pronounced Pick-a-MAb) is a ... work or to the underlying mechanism of onset, progression, and pathophysiology of the disease itself. About FcGRs: Fc gamma receptors are cell surface glycoproteins found on immune ...
Subject: PIKAMAB
Price: $3.00
*
Plan's Expertise Highlighted at Premier Health Forum
2009 NOV 23 ... American Public Health Association gathers organizations together to address current and emerging health science, policy, and practice issues in an effort to prevent disease and promote ...
Subject: Pediatrics
Price: $3.00
*
QuantRx Debuts Flagship Diagnostic Reader Device Q-Reader(TM) at MEDICA 2009, the World's Leading Medical Trade Fair
2009 NOV 24 ... Medical Devices, Pharmaceutical, Research, Medical Supplies, Science, Nanotechnolo, Emerging Technologies, Molecular Imaging, Nanotech, Technology, QuantRx Biomedical ... diagnosis of critical metabolic markers, such as those associated with thyroid disease, malignant cancers, therapeutic drugs and other medically relevant conditions, as part ...
Subject: QuantRx Biomedical Corporation
Price: $3.00
*
Research from University of Toronto provide new insights into nanotechnology
2009 NOV 23 ... St., NW, Washington, DC 20036, USA.Keywords: City:Toronto, Country:Canada, Emerging Technologies, Microfabrication, Nanostructural, Nanostructure, Nanostructures, Nanotech, ... assays of multiple biomarkers, and (ii) able to perform direct (PCR-free) readout of disease-related genes. Here we report a chip onto which we integrate novel nanostructured ...
Subject: Nanotechnology
Price: $3.00
*
Researchers at University of California target antisense technology
2009 NOV 23 ... disease caused by dystrophin mutations. The purpose of this review is to highlight two emerging therapies designed to repair the primary genetic defect, called 'exon skipping' and ...
Subject: Antisense Technology
Price: $3.00
*
Researchers at University of Chicago, Department of Medicine target myeloma
2009 NOV 23 ... (miRNAs) correlate with distinct types of hematological malignancies. There is also emerging evidence for such miRNAs expression in multiple myeloma (MM), but the identity of the ... myeloma (MM), but the identity of the miRNAs that are abnormally expressed in this disease has not been elucidated." "In the current study, we examined the miRNAs ...
Subject: Myeloma
Price: $3.00
*
Researchers at University of London, Imperial College release new data on volvulus
2009 NOV 23 ... rates, rather than their absolute values, maybe a more sensitive indicator of emerging ivermectin resistance." Churcher and colleagues published their study in ... contact T.S. Churcher, University of London Imperial College, Dept. of Infectious Disease Epidemiology, Norfolk Pl, London W2 1PG, UK. Publisher contact information ...
Subject: Volvulus
Price: $3.00
*
Researchers from California Institute of Technology describe findings in nanoparticle research
2009 NOV 23 ... Netherlands.Keywords: City:Pasadena, State:CA, Country:United States, Emerging Technologies, Nanomaterial, Nanotech, Nanotechnology, Technology, Nanoparticle Research, ... "Manganese (Mn) toxicity in humans has been observed as manganism, a disease that resembles Parkinson's disease. The mechanism of Mn toxicity and the chemical forms ...
Subject: Nanoparticle Research
Price: $3.00
*
Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018
2009 NOV 23 ... in the world's major markets and by the launch and uptake of premium-priced agents. Emerging HER2-targeting therapies that are expected to launch by 2018 include Roche/Chugai's ... percent from 2008 to 2018, largely owing to greater uptake by patients with metastatic disease. "Since its approval, Avastin has garnered substantial patient share in ...
Subject: Breast Cancer
Price: $3.00
*
Scientists at Colorado State University publish new data on Burkholderia
2009 NOV 23 ... Dept. of Microbiology Immunology & Pathology, Rocky Mt Reg Center Excellence Biodef & Emerging Inf, Fort Collins, CO 80523, USA. The publisher's contact information for ... Resistance, Drugs, Gentamicin Sulfate, Pharmaceuticals, Therapy, Treatment, Tropical Disease, Colorado State University. This article was prepared by Biotech Business ...
Subject: Burkholderia
Price: $3.00
*
Scientists at National University detail research in science
2009 NOV 23 ... NW, Washington, DC 20036, USA.Keywords: City:Singapore, Country:Singapore, Emerging Technologies, Nanoparticle, Nanotech, Nanotechnology, Silicon Nanocrystals, National ... According to recent research from Singapore, Singapore, "The detection of disease-related proteins in complex biological media demands sensitive, reliable, and low-cost ...
Subject: Science
Price: $3.00
*
Scientists at Umea University discuss research in Parkinson disease
2009 NOV 23 ... common in the probable PD group than in the controls, suggesting the possibility of an emerging atypical parkinsonian disorder. No significant MRI differences were found between ... "The aim of this study was to investigate newly diagnosed patients with Parkinson's disease (PD) with structural magnetic resonance imaging (MRI), to compare them with healthy ...
Subject: Parkinson Disease
Price: $3.00
*
Scientists at University of Milan publish research in heart disease
2009 NOV 23 ... "High-density lipoprotein (HDL) therapy is an emerging area of therapeutic development in the cardiovascular field, aimed at supplementing and ... models, but also in humans, whereas applications to other areas of cardiovascular disease have only, up to now, been tested in animal models." Parolini and ...
Subject: Heart Disease
Price: $3.00
*
Scientists at University of Sao Paulo release new data on infectious disease
2009 NOV 24 ... programs, continuous monitoring of rotavirus types is important to detect novel and emerging strains." Munford and colleagues published their study in the Journal of ...
Subject: Infectious Disease
Price: $3.00
*
Studies conducted at E. Mtisi et al on discrete and continuous dynamical systems recently published
2009 NOV 24 ... Springfield, MO 65801-2604, USA.Keywords: Country:Tanzania, Bifurcation, Emerging Technologies, Machine Learning, Discrete and Continuous Dynamical ... for the local stability of the steady states are presented. Global stability of the disease-free steady state does not hold because the two sub-models exhibit backward bifurcation. ...
Subject: Discrete and Continuous Dynamical Systems
Price: $3.00
*
Studies in the area of virology reported from J.H. Huang and co-researchers
2009 NOV 23 ... "Sendai virus vector is emerging as a promising vector for gene therapy, and angiopoietin-1 (Ang-1) has been reported to ... "It suggests that SeVhAng-1 may serve as a potential therapeutic tool in ischemic limb disease." Huang and colleagues published their study in Angiogenesis (Sendai viral ...
Subject: Virology
Price: $3.00
*
TessArae Delivers Lower Cost Option to Genetic Testing Market
2009 NOV 24 ... and definitive identification of respiratory pathogens, the RPM-TEI Kit for tropical and emerging infections, and the RPM-HFV Kit for whole genome resequencing of HFV hemorrhagic fever ... to Klaus Schafer, M.D., MPH, President and CEO of TessArae, "The human genetic disease testing market represents a new opportunity for us. Our resequencing microarray-based ...
Subject: TessArae, Llc
Price: $3.00
*
Unlocking mysteries of the brain with PET
2009 NOV 23 ... been applied to patients in other diseases."Keywords: Asia, Electronics, Emerging Technologies, Imaging Science, Japan, Molecular Imaging, Nanotech, Nanotechnology, ... major role in many neurodegenerative disorders-such as multiple sclerosis, Parkinson's disease and Alzheimer's disease-only limited data exists about the role of neuroinflammation in ...
Subject: Society of Nuclear Medicine
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login